KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Current Taxes (2016 - 2024)

Historic Current Taxes for Edwards Lifesciences (EW) over the last 15 years, with Q4 2024 value amounting to $1.3 million.

  • Edwards Lifesciences' Current Taxes fell 9838.71% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year decrease of 9838.71%. This contributed to the annual value of $1.3 million for FY2024, which is 9838.71% down from last year.
  • Edwards Lifesciences' Current Taxes amounted to $1.3 million in Q4 2024, which was down 9838.71% from $1.1 million recorded in Q3 2024.
  • In the past 5 years, Edwards Lifesciences' Current Taxes ranged from a high of $239.3 million in Q1 2020 and a low of $1.1 million during Q2 2024
  • For the 5-year period, Edwards Lifesciences' Current Taxes averaged around $137.9 million, with its median value being $143.4 million (2022).
  • As far as peak fluctuations go, Edwards Lifesciences' Current Taxes tumbled by 774.87% in 2020, and later plummeted by 9864.53% in 2024.
  • Edwards Lifesciences' Current Taxes (Quarter) stood at $215.3 million in 2020, then decreased by 11.75% to $190.0 million in 2021, then fell by 24.53% to $143.4 million in 2022, then plummeted by 43.79% to $80.6 million in 2023, then crashed by 98.39% to $1.3 million in 2024.
  • Its last three reported values are $1.3 million in Q4 2024, $1.1 million for Q3 2024, and $1.1 million during Q2 2024.